2 days Ago By ABMN Staff
Russell Investments Group Ltd. lifted its holdings in Inspire Medical Systems, Inc. ( NYSE:INSP – Free Report ) by 1,083.
9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 18,126 shares of the company’s stock after purchasing an additional 16,595 shares during the quarter. Russell Investments Group Ltd.
owned 0.06% of Inspire Medical Systems worth $3,360,000 at the end of the most recent quarter. Several other large investors also recently bought and sold shares of the business.
First Horizon Advisors Inc. grew its stake in shares of Inspire Medical Systems by 885.7% in the 4th quarter.
First Horizon Advisors Inc. now owns 138 shares of the company’s stock worth $26,000 after buying an additional 124 shares in the last quarter. Huntington National Bank lifted its holdings in shares of Inspire Medical Systems by 228.
3% in the 4th quarter. Huntington National Bank now owns 174 shares of the company’s stock valued at $32,000 after acquiring an additional 121 shares during the last quarter. Harbour Investments Inc.
grew its position in Inspire Medical Systems by 101.0% in the fourth quarter. Harbour Investments Inc.
now owns 197 shares of the company’s stock worth $37,000 after acquiring an additional 99 shares in the last quarter. AlphaQuest LLC grew its position in Inspire Medical Systems by 7,275.0% in the fourth quarter.
AlphaQuest LLC now owns 295 shares of the company’s stock worth $55,000 after acquiring an additional 291 shares in the last quarter. Finally, Smartleaf Asset Management LLC increased its stake in Inspire Medical Systems by 178.9% during the fourth quarter.
Smartleaf Asset Management LLC now owns 357 shares of the company’s stock worth $66,000 after acquiring an additional 229 shares during the last quarter. Institutional investors own 94.91% of the company’s stock.
Inspire Medical Systems Price Performance Shares of INSP opened at $146.82 on Thursday. The firm has a market capitalization of $4.
37 billion, a price-to-earnings ratio of 84.87, a PEG ratio of 2.86 and a beta of 1.
39. The company has a 50-day moving average of $167.43 and a 200 day moving average of $184.
23. Inspire Medical Systems, Inc. has a 1-year low of $123.
00 and a 1-year high of $257.40. Analyst Upgrades and Downgrades Several equities research analysts have recently issued reports on the company.
KeyCorp reaffirmed an “overweight” rating and issued a $234.00 price objective (down from $236.00) on shares of Inspire Medical Systems in a research note on Friday, January 24th.
Robert W. Baird dropped their price objective on shares of Inspire Medical Systems from $252.00 to $248.
00 and set an “outperform” rating for the company in a research note on Tuesday, February 11th. Truist Financial cut their price objective on shares of Inspire Medical Systems from $250.00 to $235.
00 and set a “buy” rating on the stock in a research report on Tuesday, February 11th. Stifel Nicolaus lowered their target price on shares of Inspire Medical Systems from $200.00 to $190.
00 and set a “hold” rating for the company in a report on Tuesday, January 21st. Finally, Royal Bank of Canada dropped their price target on shares of Inspire Medical Systems from $260.00 to $215.
00 and set an “outperform” rating for the company in a research note on Tuesday. Three equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $222.
20. View Our Latest Report on Inspire Medical Systems Insiders Place Their Bets In other Inspire Medical Systems news, insider Randy Ban sold 25,584 shares of the company’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $183.
50, for a total transaction of $4,694,664.00. Following the completion of the sale, the insider now owns 7,259 shares in the company, valued at $1,332,026.
50. This represents a 77.90 % decrease in their ownership of the stock.
The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website . Also, CTO John Rondoni sold 583 shares of the stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $170.
49, for a total value of $99,395.67. Following the sale, the chief technology officer now directly owns 10,424 shares in the company, valued at $1,777,187.
76. This trade represents a 5.30 % decrease in their position.
The disclosure for this sale can be found here . Company insiders own 4.10% of the company’s stock.
About Inspire Medical Systems ( Free Report ) Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. Recommended Stories Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.
com's FREE daily email newsletter ..
_0.jpg?itok=yAIF6nFK)
